LIFEVANTAGE CORP Operating Leases, Rent Expense
LIFEVANTAGE CORP (LFVN) reported Operating Leases, Rent Expense of $2.70 million for the 12-month period ending 2019-06-30, per its 10-K filed 2021-08-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-08-19
- LIFEVANTAGE CORP operating leases, rent expense for fiscal 2019 was $2.70M, a 0.00% change from fiscal 2018.
- LIFEVANTAGE CORP operating leases, rent expense for fiscal 2018 was $2.70M.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2019-06-30 | $2.70M 10-K · filed 2021-08-19 |
| 2018-06-30 | $2.70M 10-K · filed 2020-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |